InCred Equities initiated coverage on Artemis Medicare with a 'Buy' rating for a target price of ₹437, anticipating healthy earnings growth driven by additions in operational beds.
Artemis Medicare surges 14% on huge volume; zooms 87% from April low
By system
September 26, 2026 •
128 views
Original source:
Business Standard